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Trichorhinophalangeal syndrome (TRPS), a type of skeletal dysplasia, is characterized by a triad of dysmorphic (bulbous nose and
large ears); ectodermal (thin and sparse hair); and skeletal (short stature and cone-shaped epiphyses) findings, and this
combination is helpful for early diagnosis and appropriate follow-up. A 14-year-old boy presented with short stature and
distinctive facial features, and following the first clinical and biological evaluation, no precise diagnosis was reached. Progressive
bilateral development of noninflammatory and painless deformity of his second finger required a radiological exam that
highlighted the key elements (cone-shaped epiphyses) for final diagnosis.'is case illustrates the difficulties to early recognition of
TRPS when the clinical presentation is not complete and radiological findings are missing.
1. Introduction
Skeletal dysplasias are a group of 436 well-delineated dis-
orders [1], caused by disturbance of bone growth and
characterized by variable phenotypical expressions, in-
cluding short stature (typically nonendocrine), facial de-
formities, multisystem involvement (ocular, cutaneous,
cardiac, gastrointestinal, genital, and neurological), and
different radiological abnormalities. 'e genetic background
becomes more and more detailed, with 364 genes described
today [1].
Trichorhinophalangeal syndrome (TRPS) is a rare
inherited skeletal dysplasia with characteristic physical
features (pear-shaped nose, thin and sparse hair, and
prominent ears) and abnormalities of the fingers and/or
toes. As the range and severity of the phenotype expression
is variable, the clinical diagnosis can be missed or un-
reported. 'e diagnosis is usually suspected on a physical
background and confirmed by radiographic studies of the
skeleton, showing distinctive abnormalities of the hands,
feet (epiphyseal coning), and pelvis, (small, flat, or frag-
mented femoral heads in some patients). Molecular genetic
analysis can be used to identify mutations of the TRPS gene.
'ree different types are described (types I, II, and III)
with some common and distinctive clinical and radiological
features and different genetic abnormalities.
2. Case Presentation
A 14-year-old adolescent boy was referred to our Endo-
crinology Department for evaluation of short stature. As no
medical records were available, previous growth velocity
could not be evaluated. 'e patient reported that he had
always been short for his age throughout his childhood.
His recent medical history was negative for headaches,
vomiting, or vision changes. 'ere were no reports of fa-
tigue, cold intolerance, constipation, and skin or hair
changes. Appetite was normal with no recent weight loss.
'ere were no academic concerns. He regularly played
football, with no history of traumatic or nontraumatic
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fractures. He took no medications. For several months, he
had reported minor bilateral symmetrical crookedness on
his second fingers, without any pain or local symptoms.
He had been born at 36 gestational weeks, weighing
2450 g with no history of abnormal gestation, breech pre-
sentation, ischemic insult at birth, or other neonatal events.
Parental heights were normal, with a target height of
177.5 cm. Parental pubertal timing was also within normal
limits. Family history was negative for short stature, en-
docrine, or autoimmune conditions.
Clinical examination revealed a dysmorphic, pro-
portionate, and relatively short adolescent with normal vital
signs. His anthropometric parameters were −2 SDs (standard
deviations) for weight (37 kg) and between −2 SDs and −2.5
SDs for height (148 cm) (Belgian charts). His height was below
his midparental genetic interval. His upper:lower segment
ratio and arm span were normal. His hands and feet appeared
short, with middle, painless tumefaction of soft tissue around
the index proximal interphalangeal joints. No spinal abnor-
malities were noted, but a mild pectus excavatumwas present.
'ere was no thyromegaly. Testicular and pubic hair devel-
opment was in Tanner stage II (testicular volume 6ml). 'e
most prominent dysmorphic features were a pear-shaped
nose, a thin upper lip with small lower jaw, prominent
ears, and markedly thin and sparse blonde hair with rare-
faction of the lateral eyebrows (Figure 1). 'e teeth exami-
nation was difficult because he wore dental braces to correct
dental irregularities.
An extensive biological workup was performed. Com-
plete blood count and serum levels of inflammatorymarkers,
electrolytes, glucose, renal function, liver enzyme, and tissue
transglutaminase antibody levels were normal. 'e labora-
tory findings showed normal thyroid and adrenal function
and normal growth hormone secretion (normal levels of
insulin-like growth factor and insulin-like growth factor
binding protein). Additional pituitary and gonad testing
revealed a normal prolactin level and pubertal testosterone,
luteinizing hormone (LH), and follicle-stimulating hormone
(FSH) levels (Table 1).'e bone age was evaluated at 12 years
6 months.
A renal and cardiac ultrasound looking for other possible
somatic malformations [2] wasperformed and showed
normal morphological kidneys, ureters, and urinary bladder
and no cardiac abnormalities.
After this first clinical, biological, and radiological
evaluation, the working diagnosis was constitutional growth
delay with late normal puberty, but skeletal dysplasia
(dysmorphic features in the context of short stature) was
considered for differential diagnosis.
During the follow-up 6 months later, the initial apparent
soft tissue tumefaction of his indexes had progressed to
localized noninflammatory and painless deformity, causing
limited difficulty in writing and typing on a keyboard. 'is
sign was isolated, and the patient did not complain of pain or
history of local trauma or infection. At this time, his clinical
appearance was normal, except for the aforementioned
dysmorphic traits. His growth velocity (5 cm/6months) was
normal in the context of spontaneous pubertal progress
(Tanner stage III, testicular volume 8–10ml).
Clinical examination of his hands revealed isolated ulnar
deviation of the second fingers and symmetrical deformity of
proximal interphalangeal joints of both hands (Figure 2). He
had no other painful or deformed joints.
His feet look normal, but the toes are short (Figure 3).
'eoretically, a differential diagnosis with in-
flammatory arthritis was considered, but the clinical
findings (dysmorphic features, short stature, and relatively
asymptomatic finger abnormalities) were more suggestive
of a skeletal dysplasia. Radiographs of hands, feet, and
pelvis were performed and allowed the definitive
diagnosis.
'e plain radiograph of his wrists showed cone-shaped
epiphyses of the middle phalanges of the second digit of both
Figure 1: Typical dysmorphic facial features.
Table 1: Patient’s endocrine workup.
Patient References
'yroid function
TSH 2.7 0.5–4.5mU/L
T4 10.25 4.5–12.5 µg/dL
Growth hormone secretion
IGF1 345 106–435 ng/mL(Tanner stage II)
IGFBP3 5.0 2.8–6.3 µg/mL(Tanner stage II)
Adrenal function
Cortisol 530 150–800 nmol/L
ACTH 54 8–90 ng/L
Prolactin 5 2–18 ng/mL
Gonadotrophins
FSH 5.0 4.7–9.5mIU/mL
LH 4.3 2.1–13mIU/mL
Gonadal function Testosterone 1200 310–7200 ng/L
IGF1, insulin-like growth factor 1; IGFBP3, insulin-like growth factor
binding protein 3; ACTH, adrenocorticotropic hormone.
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hands with moderate deviation of the phalangeal axis
(Figures 4(a) and 4(b)).
Similar cone-shaped epiphyses were found in the
proximal phalanx of the great toe and up to the fourth one of
both feet with shortness of all toes (Figure 5).
No other radiological joint impairments (juxtaarticular
osteopenia or erosions) were found. Radiographs of the
pelvis and whole-body magnetic resonance imaging (look-
ing for fine abnormalities, particularly long bone cysts not
visible on plain radiographs) [3] were normal. 'e bone age
was retarded at 12 years 6 months (the chronological age was
14 years 6 months).
Taking together the clinical and particularly the radio-
logical findings, the correct diagnosis of tricho-
rhinophalangeal syndrome (TRPS) was achieved. 'is was a
delayed diagnosis, and our explanations for this include the
underrecognition of the dysmorphic features (in our first
examination), the underinterpretation of fingers tumefac-
tion in the clinical context, and consecutively no hand ra-
diological exam being conducted.
Other entities associating ectodermal and skeletal phe-
notypes were reviewed, particularly Albright osteodys-
trophy, acrodysostosis, and other brachydactyly syndromes,
but several features of the presentation were inconsistent
with these diagnoses.
Cytogenetic analysis was not performed. 'e family
history appeared to be negative, his parents and his sister do
not manifest the syndrome phenotype, and in such condi-
tions, a sporadic case of TRPS type I was considered highly
possible.
3. Discussion
TRPS is a rare skeletal disease associated with craniofacial,
ectodermal, and skeletal findings. Two types are described
with relatively similar clinical phenotypes but with dis-
tinctive radiological and genetic characteristics.
Defined by Giedion in 1966, type I is characterized by a
triad of craniofacial, ectodermal, and skeletal abnormalities,
with high penetrance and variable expressivity.
'emost dysmorphic facial trait concerns the large nose,
with a broad ridge and tip and underdeveloped alae. Other
facial findings include scanty lateral eyebrows, a long
philtrum with thin upper vermillion, maxillary prognathism
with mandibular hypoplasia, and large prominent ears. 'e
ectodermal elements include fine, sparse, depigmented, and
slow-growing hair and dystrophic nails. 'e skeletal char-
acteristics specifically concern the hands and feet, with a
clinical appearance of brachydactyly with ulnar or radial
deviation of the fingers and short feet. 'e most charac-
teristic radiologic abnormality involves the middle pha-
langes of the hands and feet and consists of an enlarged,
irregular metaphyseal ending, with the shape of a cone or
inverted V. 'e proximal or distal phalanges and some
tubular bones (metacarpals) could also be affected [4]. Hip
dysplasia (coxa plana, coxa magna, and coxa vara) is fre-
quently found [5], and in pediatric patients, this hip in-
volvement requires particular attention in order to provide a
differential diagnosis with Perthes disease.
Epiphyseal changes are associated with retarded skeletal
age and short stature, with a final adult height below the 50th
percentile [6]. Other skeletal abnormalities, such as severe
osteoporosis, have also recently been reported [7]. 'e di-
agnosis of TRPS I is clinical and radiological due to the
association of characteristic physical features and specific
abnormalities of the hands and feet, particularly epiphyseal
coning. Molecular genetic analysis can reveal a heterozygous
pathogenic variant in the TRPS1 gene on chromosome 8
(deletions, nonsense, and missense mutations). 'ere are no
genotype-phenotype correlations in TRPS I, and a certain
clinical variability (sometimes with subtle clinical changes) is
Figure 3: Feet abnormalities with short toes.
Figure 2: Symmetrical deformity of proximal interphalangeal
joints of both hands.
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observed within and among families with the same TRPS1
pathogenic variant [5, 8, 9].
Many cases could remain undiagnosed until one or
several disturbing signs (short stature, sparse hair, painless
swelling of the proximal interphalangeal joints, and hip
pain) bring the patient to seek medical attention.
TRPS type II (Langer–Giedion syndrome) presents
with the same phenotype as TRPS type I, and its charac-
teristic features include multiple osteochondromas (scap-
ulae, elbows, and knees) and mild-to-moderate intellectual
disability [10]. Bone involvement also includes cone-
shaped epiphyses of the phalanges of the hands with de-
formity of the fingers, delayed bone age, osteochondromas,
and hip malformations. Multiple long bone cysts with
pathological fractures have recently been described in a
case report [3].
Most individuals with TRPS II have de novo contiguous
gene deletion involving the TRPS1, RAD21, and EXT1 on
chromosome 8.
TRPS type III (Sugio-Kajii syndrome) is an extremely
rare autosomal dominant variant presenting a similar dys-
morphic phenotype with abnormalities of the hands and
feet. Inflammation of the bone and cartilage in the spinal
column (osteochondritis) and spinal abnormalities (scoli-
osis) is relatively particular for this type.
'e endocrine elements of TRPS, particularly delayed
bone age during childhood and decelerated growth with adult
short stature, are well described clinically, but their un-
derlying pathological mechanisms remain poorly understood.
'e currently available clinical therapies for patients
with skeletal dysplasia, including the TRPS, are pre-
dominantly palliative in nature. Joint pain can be alleviated
using nonsteroidal antiinflammatory drugs and the pro-
gression of skeletal deformations/abnormalities can be di-
minished by physiotherapy, occupational therapy, or in
extreme cases, by prosthetic hip implantation (severe hip
dysplasia).
Reduced linear growth and subsequently adult short
stature are usually found in TRPS syndrome. 'e growth
hormone secretion is usually normal, but when the height
velocity is abnormal for pubertal development and sex, the
diagnosis of growth hormone deficiency should be evalu-
ated. Several TRPS cases with growth hormone deficiency or
insensitivity are reported [11, 12]. Growth hormone therapy
has been shown to improve growth and height outcome in
(a) (b)
Figure 4: (a) Cone-shaped epiphyses of the middle phalanges of the second digit of both hands and (b) magnification of the cone-shaped
epiphyses.
Figure 5: Cone-shaped epiphyses with shortness of the toes.
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TRPS children, but to date the definitive results are still
missing.
Several pharmacotherapeutic options/therapies are un-
der investigation for certain skeletal dysplasias, and these
include in utero stem cell transplantation, stem cell trans-
plantation, chaperone therapy, gene therapy, bone marrow
transplant, C-type natriuretic peptides, and enzyme re-
placement therapy [13].
4. Conclusion
We reported a case of a short adolescent with clinical and
radiological features that were highly suggestive for TRPS
type I. 'e first clinical diagnosis (constitutional growth
delay versus skeletal dysplasia) was incorrect, but 6 months
later, collaborative work with the radiology team consid-
erably narrowed the diagnosis options to those among the
skeletal dysplasia types. Interpreting the clinical phenotype
and the radiological aspects, namely, cone-shaped epiphyses,
together was very helpful to the diagnostic approach. A
confirmatory genetic diagnosis was not available.
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